Astellas US LLC et al v. Dr. Reddy's Laboratories, Ltd. et al
| Gilead Sciences, Inc., Astellas US LLC and Astellas Pharma US, Inc. |
| Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc. |
| 1:2019cv01160 |
| June 21, 2019 |
| US District Court for the District of Delaware |
| Colm F Connolly |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on August 15, 2019. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 9 STIPULATION Conslidate Action with C.A. No. 18-1675 by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Filing 8 NOTICE OF SERVICE of Plaintiffs' Fed. R. Civ. P. 26(a)(1) Initial Disclosures and Disclosures Pursuant to Paragraph 3 and 4a of the Delaware Default Standard filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
SO ORDERED, re #7 MOTION for Pro Hac Vice Appearance of Attorney Lisa M. Ferri and Manuel J. Velez filed by Gilead Sciences, Inc. Signed by Judge Colm F. Connolly on 6/27/2019. (nmf)
|
| Filing 7 MOTION for Pro Hac Vice Appearance of Attorney Lisa M. Ferri and Manuel J. Velez - filed by Gilead Sciences, Inc.. (Oakes, Robert) |
| Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (nmg) |
| Filing 6 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Astellas US Holding, Inc. for Astellas Pharma US, Inc., Astellas US LLC filed by Astellas Pharma US, Inc., Astellas US LLC. (myr) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Gilead Sciences, Inc.. (myr) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,106,183 ;US RE 47,301 E ;US 8,524,883. (myr) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 5/14/2019. Date of Expiration of Patent: 2/2/2027.Thirty Month Stay Deadline: 11/14/2021. (myr) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (myr) |
| Filing 1 COMPLAINT FOR PATENT INFRINGEMENT filed against Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-2670511.) - filed by Astellas US LLC, Astellas Pharma US, Inc., Gilead Sciences, Inc.. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Civil Cover Sheet)(myr) |
| No Summons Issued. (myr) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
